Omental Islet Transplant

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 13, 2019

Study Completion Date

November 13, 2019

Conditions
Type 1 Diabetes
Interventions
PROCEDURE

Omental Islet transplant

The intervention is transplanting the islets into an omental pouch instead of into the liver. The omentum is a large apron-like fold of membrane inside the abdomen that drapes over the intestines. This study will test to see if omental islet transplantation is safe and effective. Standard immunosuppressive medicines (anti-thymocyte globulin, tacrolimus, mycophenolic acid, sirolimus, etanercept) will be used in this study to prevent rejection of the islets.

DRUG

Anti-Thymocyte Globulin

DRUG

Mycophenolate mofetil

DRUG

Tacrolimus

DRUG

Etanercept

DRUG

Sirolimus

Sirolimus will be used in case of tacrolimus or/and mycophenolate mofetil intolerance.

Trial Locations (1)

T6G2C8

Clinical Islet Transplant Program, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT02821026 - Omental Islet Transplant | Biotech Hunter | Biotech Hunter